ChemoCentryx, Inc. (CCXI) Social Stream



ChemoCentryx, Inc. (CCXI): $25.08

-0.92 (-3.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CCXI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

ChemoCentryx Inc (CCXI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CCXI.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 6 $107 $38 $74.5 $25.71 189.77%
2022-03-02 6 $110 $40 $75.333 $25.71 193.01%
2022-03-03 6 $110 $30 $73.666 $25.71 186.53%

The Trend in the Analyst Price Target


Over the past 14 months, CCXI's average price target has gone down $6.96.

Over the past 46 weeks, CCXI's average upside potential has been 142.38%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-24 8 79 17 36.570 13.06 180.02%
2021-08-01 8 79 17 37.290 14.78 152.3%
2021-08-14 8 64 17 35.140 14.00 151%
2022-02-27 6 110 40 75.333 30.63 145.95%
2022-03-02 6 110 40 75.333 24.55 206.86%

CCXI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

The Trend in the Broker Recommendations


CCXI's average broker recommendation rating improved by 0 over the prior 120 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, ChemoCentryx Inc's variance in analysts' estimates is lower than -266.15% of them.
  • To contextualize these metrics, consider that out of all US stocks, ChemoCentryx Inc's upside potential (average analyst target price relative to current price) is higher than 352.21% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ChemoCentryx Inc's average analyst price target is higher than 323.16% of them.
  • In the context of stocks in the mid market cap category, ChemoCentryx Inc's number of analysts covering the stock is higher than 150.04% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ChemoCentryx Inc are BPMC, BHVN, and BBIO.

What is the outlook for CCXI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4978 seconds.